secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001104659-25-067561
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio announces 1-for-20 reverse stock split effective July 14, 2025
--------------------------------------------------------------------------

- Reverse split ratio 1-for-20; effective 12:01 a.m. ET on July 14, 2025.
- Pre-split shares ~62.4M; post-split ~3.12M shares outstanding.
- Action intended to regain Nasdaq minimum $1.00 bid price compliance.
- No fractional shares; holders of fractional shares receive rounded-up whole share.
- No change to authorized shares (125M), par value ($0.0001), or voting rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465925067561/0001104659-25-067561-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465925067561/tm2520584d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-067561

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer